Global Search | Novartis

Sort by

Relevance

Newest first

Oldest first

Hide Filters

Showing 189 results

Featured News / Oct 14, 2021

World Sight Day 2021

Novartis is working with partners around the world to help eliminate preventable visual impairment and blindness by reimagining access to eye care.
Statement / Apr 19, 2022

Novartis provides more than USD 25 million in medical aid to patients in Ukraine and bordering countries
Statement / Mar 22, 2022

Novartis condemns the war in Ukraine - update March 22
Statement / Mar 04, 2022

Novartis condemns the war in Ukraine and commits to supporting humanitarian efforts
Statement / Mar 08, 2022

Novartis expands humanitarian efforts in Ukraine through donation of essential medicines
Statement / Feb 15, 2022

Novartis announces European Patent Office orders grant of the European Gilenya® (fingolimod) 0.5mg daily dose patent
Statement / Jan 24, 2022

2021 Global Managed Access Program Community Update
Pulse Update / Dec 16, 2021

Novartis receives FDA Fast Track designation for branaplam (LMI070) for the treatment of Huntington’s Disease
Pulse Update / Aug 30, 2021

Novartis sabatolimab receives orphan drug designation from the European Commission for myelodysplastic syndromes
Pulse Update / Sep 28, 2021

FDA grants Priority Review for investigational targeted radioligand therapy 177Lu-PSMA-617 for patients with metastatic castration-resistant prostate cancer (mCRPC)